Pharmacokinetic modeling and simulation of biweekly subcutaneous immunoglobulin dosing in primary immunodeficiency

Postgraduate medicine

Volumn 125, Issue 6, 2013, Pages 53-61

  Landersdorfer, Cornelia B ^a   Bexon, Martin ^a   Edelman, Jonathan ^a   Rojavin, Mikhail ^a   Kirkpatrick, Carl M J ^a   Lu, Jianfeng ^a   Pfister, Marc ^a   Sidhu, Jagdev ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

AREA UNDER THE CURVE; BIOLOGICAL MODEL; COMPUTER SIMULATION; DOSE RESPONSE; DRUG ADMINISTRATION; HALF LIFE TIME; HUMAN; IMMUNOLOGIC DEFICIENCY SYNDROMES; INTRAVENOUS DRUG ADMINISTRATION; METABOLIC CLEARANCE RATE; METABOLISM; PHASE 3 CLINICAL TRIAL (TOPIC); SUBCUTANEOUS DRUG ADMINISTRATION;

AREA UNDER CURVE; CLINICAL TRIALS, PHASE III AS TOPIC; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HALF-LIFE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL;

EID: 84891719754     PISSN: None     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2013.11.2712     Document Type: Article

References (0)